Skip to main content
Premium Trial:

Request an Annual Quote

Biogemma Licenses Evogene's Corn Genes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biogemma has licensed rights to genes from Evogene that it will use to develop corn hybrids with improved yield and drought tolerance, Evogene said today.

The corn lines Paris-based Biogemma will develop under the worldwide, exclusive agreement include genes that the companies evaluated under a collaboration agreement that was started in 2006. Biogemma and Evogene validated corn lines incorporating these genes through field trials in the US and in Israel over the past two years.

"Improved plant yield and drought tolerance are perhaps the most critical needs in today's worldwide agriculture, and as such are key targets for Evogene's ag-bio trait program," Ofer Haviv, Evogene's president and CEO, said in a statement.

Rehovot, Israel-based Evogene's core platform uses computational technologies for gene discovery and high-throughput systems for gene validation.

Financial terms of the agreement were not released.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.